The unveiling ceremony of the National Precision Medicine Industry Innovation Center was successfully held in Chengdu. Huaxi Hospital and Zhongyuan Sheikh Cell Genetic Engineering Co., Ltd. signed the Cooperation Agreement on Building National Precision Medicine Industry Innovation Center respectively, and cooperated with * * * to build the project of Precision Medicine Industry Innovation Center, which marked the official landing of the first national industrial innovation center in Sichuan Province and the only approved national industrial innovation center in biomedical field in China.
0 1 Wuhan Optics Valley Zhongyuan Concord Cell Gene Technology Co., Ltd., a subsidiary of Zhongyuan Concord, won the "First Prize of Hubei Science and Technology Progress" for the project of "Key Technology Innovation and Clinical Application in Diagnosis and Treatment of Ovarian Dysfunction".
202 1.
12 The first stem cell forum of the Third Hospital of Peking University hosted by the Third Hospital of Peking University-the Central Plains Sheikh Cell Storage and Application Joint R&D Center was successfully held. Sheikh Zhongyuan was invited to attend, which was highly recognized by academicians and experts, and promoted the high-quality development of stem cell research in China.
1 1 Tianjin Municipal Health and Wellness Committee issued the "Practice License for Blood Station" (Jin 004) to Tianjin Umbilical Cord Blood Hematopoietic Stem Cell Bank under Sheikh of Zhongyuan.
1 1 Cell Ecology Haihe Laboratory was officially unveiled in Tianjin Binhai High-tech Zone, and Central Plains Sheikh was hired as a cooperative enterprise to promote the innovative development of the cell industry.
1 1 "World Umbilical Cord Blood Day" public welfare forum and the 20th anniversary celebration of the establishment of Tianjin Umbilical Cord Blood Bank were held in Tianjin Tianta. Many experts from the industry gathered together to popularize the valuable value of umbilical cord blood. Wei, the Olympic champion, served as the umbilical cord blood ambassador.
11"2021(6th) Zhongyuan Concord Prize in Life Medicine" was successfully held in Beijing. The meeting officially announced the list of members of the new Central Plains Concord Prize for Life and Medicine, and held an appointment ceremony. After a scientific, standardized and reasonable evaluation procedure, the members of the evaluation committee finally selected the winner of the 6th Zhongyuan Concord Prize in Life Medicine.
10 There are more than 3,000 applications for umbilical cord blood in Tianjin umbilical cord blood bank under Zhongyuan Xiehe.
The Third Hospital of Beijing Medical University-Zhongyuan Sheikh Cell Storage and Application Joint R&D Center was officially unveiled in the Third Hospital of Peking University. The two sides will carry out comprehensive strategic cooperation in cell research and development, cell storage and cell application, promote the filing of stem cell clinical research, and build a clinical demonstration base for cell storage and application in Beijing, Tianjin and Hebei.
In 2009, the national key research and development plan "Multi-center clinical study of human bone marrow mesenchymal stem cells in the treatment of severe liver disease" was officially launched, and Zhongyuan Concord provided the guarantee of stem cell preparation.
Concord East China Stem Cell Genetic Engineering Co., Ltd., a subsidiary of Zhongyuan Concord, signed a strategic cooperation framework agreement with Huzhou Central Hospital and Huzhou Maternal and Child Health Hospital to build a highland of precision medical industry in northern Zhejiang and even the Yangtze River Delta.
In 2003, Sheikh Zhongyuan participated in the publication of the first international expert's Knowledge of Mesenchymal Stem Cells Treating novel coronavirus, which provided norms and guidance for clinical research and practice.
0 1 Central Plains Sheikh received a thank-you letter from the Ministry of Science and Technology, affirming the company's work and efforts in participating in emergency scientific research projects for epidemic prevention and control.
2020.
12 2020 (5th) Zhongyuan Concord Biomedical Awards Ceremony and Summit Forum was held in Wuhan. The meeting announced the winners of the new Zhongyuan Concord Prize in Life Medicine, and 50 young scientists jointly launched the Alliance of Young Scientists of Zhongyuan Concord Prize in Life Medicine.
12 "Hubei Human Stem Cell Preparation, Application and Resource Conservation Engineering Research Center", supported by Reproductive Medicine Center of Tongji Medical College and established by Wuhan Optics Valley Zhongyuan Concord Cell Gene Technology Co., Ltd., a subsidiary of Zhongyuan Concord, passed the evaluation and became the first stem cell engineering research center in Hubei Province.
Sheikh Zhongyuan was invited to attend the 13th China Bio-industry Conference. During the meeting, Zhongyuan Concord signed a contract with Optics Valley Bio-City, and the first batch settled in the frontier biotechnology industrial park.
Wuhan Optics Valley Zhongyuan Concord Cell Gene Technology Co., Ltd., a subsidiary of Zhongyuan Concord, and tongji hospital, a subsidiary of Tongji Medical College of Huazhong University of Science and Technology, completed the filing of stem cell clinical filing research projects. So far, the number of stem cell clinical research filing projects of the National Health and Family Planning Commission that Zhongyuan Sheikh Company participated in and completed has reached six.
20 19.
1 1 The application of cord blood in Tianjin cord blood bank, a subsidiary of Central Plains Sheikh, exceeded 2000 cases.
10 20 19 (the 4th) Zhongyuan Concord Biomedical Awards Ceremony and Summit Forum was held in Beijing.
A series of activities of "Science and Technology Olympic Academicians Union" were successfully held in Zhongyuan Concord. Xu Haifeng, the first gold medal winner of China Olympic Games, was hired as the public welfare promotion ambassador of "Science and Technology Olympic Academicians Union" to help the Science and Technology Olympic Games. Up to now, * * * 13 Olympic champions have actively participated in the activities and entered Zhongyuan Concord National Stem Cell Engineering Product Industrialization Base, so that life science and technology can empower the Olympic Games.
Wuhan Optics Valley Zhongyuan Concord Cell Gene Technology Co., Ltd. was officially unveiled, and the national network layout of Zhongyuan Concord was further deepened.
The stem cell clinical research project declared by Central Plains Sheikh and the First Hospital of Lanzhou University won the double record of "institution+project" for the first time, and the development of the company's stem cell field reached a new level. So far, there have been three application projects for stem cell clinical research by the National Health Commission in Sheikh, Zhongyuan.
Academician Karl. June, the most influential scientist in the global biopharmaceutical industry and one of the founders of CAR-T cell therapy, a tenured professor at perelman School of Medicine, University of Pennsylvania, officially signed the contract of "Zhongyuan Concord Scientific Consultant".
20 18.
12 The Hematology Hospital of China Academy of Medical Sciences (Institute of Hematology) held the 20 18 annual meeting on science and technology in Zhongyuan Concord. At the meeting, the launching ceremony of the Garden Campus of Hematology Hospital (Institute of Hematology) of China Academy of Medical Sciences was held.
1 120 18 (2nd) Life Science Innovation and Development Summit and the 3rd Zhongyuan Concord Life Medicine Award Presentation Ceremony were held in Tianjin. The meeting announced the winners of the new Central Plains Concord Life Medicine Award, and a number of academicians and Olympic champions jointly launched the "Science and Technology Olympic Academician Alliance" to actively help "Healthy China".
In 2009, Central Plains Sheikh and Sheikh Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology completed the stem cell clinical research project filing, which marked the company's breakthrough in the national stem cell clinical filing research project.
Company 08 successfully acquired Aorui Dongyuan, a wholly-owned subsidiary of Shanghai Aoyuan, and the "accurate diagnosis" business formed a strong synergy to build a complete precision medical industry chain.
The overseas platform of Hematology Hospital (Institute of Hematology) of China Academy of Medical Sciences and the overseas transformation research center of the State Key Laboratory of Experimental Hematology settled in the Central Plains Sheikh American Company.
20 17.
The total number of umbilical cord blood applications in Tianjin Cord Blood Bank, a subsidiary of 12 Company, has exceeded 1200 cases, achieving a rapid growth in cord blood applications for five consecutive years.
12 "2017 Life Science Innovation and Development Summit Forum" was held in Tianjin High-tech Zone.
1 1 20 17 (the second) Zhongyuan Concord Biomedical Awards Ceremony and Summit Forum was held in the auditorium of Yanqi Lake Campus, Chinese Academy of Sciences.
Zhongyuan Concord and Wuhan National Bio-industrial Base Construction Management Office held the signing ceremony of "Wuhan National Bio-industrial Base Project Entry Agreement-Zhongyuan Concord settled in Wuhan Optics Valley Bio-city", which opened a new chapter in the company's national network layout.
The Blood Hospital of China Academy of Medical Sciences (Institute of Hematology) and Central Plains Sheikh deepened their strategic cooperation and worked together to build a national Industry-University-Research innovation demonstration platform.
The Institute of Science and Technology of the National Health and Family Planning Commission and its subsidiary Tianjin Umbilical Cord Blood Hematopoietic Stem Cell Bank signed the data transmission agreement of "National Umbilical Cord Blood Hematopoietic Stem Cell Resource Service Platform" in Tianjin, and Tianjin Umbilical Cord Blood Bank became the umbilical cord blood bank for storing data.
03 20 17 The launching ceremony of the second Zhongyuan Concord Prize for Life Medicine was held in Beijing. Nobel Prize winner James? Professor Watson, Academician Bai Chunli, President of Chinese Academy of Sciences, and other heavyweight guests attended.
Zhongyuan Concord officially launched a brand-new service brand of "Internet Plus Health"-"Kangaroo Health Insurance", creating a new model of national health insurance.
20 16.
12 The first prize awarding ceremony of Zhongyuan Concord Life Medicine Award and the International Precision Medicine Summit Forum were successfully held in Beijing National Convention Center.
Company 09 participated in the establishment of E-Ang Biotechnology (Shanghai) Co., Ltd., dedicated to the clinical research of CAR-T solid tumor.
In 2009, the company held a signing ceremony with the University of Chinese Academy of Sciences, and * * * established the "Zhongyuan Concord Life Medicine Award".
The application for drug registration of the new drug "Human Dental Pulp Mesenchymal Stem Cell Injection" by Sheikh Zhongyuan was accepted by the US Food and Drug Administration in Beijing.
In 2009, the subsidiary and biotechnology transformation center established by Zhongyuan Concord in the United States was officially unveiled, and the company took an important step in the global strategic layout.
In order to accelerate the realization of the strategic goal of "cell+gene" dual-core drive and promote the sustainable development of the company's business, the company established Zhongyuan Sheikh Biological Cell Storage Service (Tianjin) Co., Ltd. ..
Zhongyuan Concord Holdings Zhejiang Cezanne Pharmaceutical Technology Co., Ltd., through this acquisition, Zhongyuan Concord will enter the automation equipment manufacturing link of immune cell industry.